Selected Grants
A Phase 1, Open-label, Preliminary Pharmacokinetics (PK) and Safety Study of CLN-049 (An fms-like tyrosine kinase 3 [FLT3] x cluster of differentiation 3 [CD3] bispecific T cell engager) in Patients with Relapsed/Refractory Acute Myeloid Leukemia (A
Clinical TrialPrincipal Investigator · Awarded by Cullinan Florentine Corporation · 2024 - 2029Exploring the impact of conditioning regimen selection on clinical outcomes and quality of life in
ResearchPrincipal Investigator · Awarded by American Society of Hematology · 2024 - 2026Fellowships, Gifts, and Supported Research
Young Investigator Pilot Award ·
January 2024
- December 2024
PI Mentor ·
Awarded by: Duke Cancer Institute
Project title: Understanding Disparities in Biobanking Participation among Minoritized Patients Undergoing HSCT in Durham, NC
ACCESS Initiative ·
August 2023
Principal Investigator ·
Awarded by: National Marrow Donor Program and American Society of Transplantation and Cellular Therapy
Ongoing
Pilot Award ·
July 2023
- May 2025
Principal Investigator ·
Awarded by: Duke Cancer Institute
Project Title: Referral Pattern and Equitable Access to Cellular Therapies for Hematologic Malignancies
Health Services Working Committee ·
April 2023
Principal Investigator ·
Awarded by: Center for International Blood and Marrow Transplant Research
Ongoing
Professional Development Grant ·
July 2019
- December 2019
Awarded by: Cleveland Clinic Alumni Association
HONORS Award ·
June 2015
- May 2016
Awarded by: American Society of Hematology
R25 Grant ·
July 2011
- August 2011
Student researcher ·
Awarded by: NHLBI
HL096240
External Relationships
- Guidepoint
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.